L. Ellis

Molecular Biology · Journal of Clinical Oncology · 2000–2016

A researcher in the Science corpus: 9 papers; trusts 9 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 85 citations into it; #7,412 of 17,773 by trust here, #7,496 by citations
• Oncology — 64 citations into it; #534 of 1,698 by trust here, #662 by citations
• Cancer Research — 45 citations into it; #531 of 1,780 by trust here, #999 by citations

Whom L. Ellis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Jacques Banchereau
2. D. Hicklin
3. Rakesh K. Jain
4. Shahin Rafii
5. K. Alitalo
6. G. Klement
7. G. Bergers
8. D. Lyden
9. D. Hanahan
10. R. Kerbel

Who trusts L. Ellis overall

1. Y. Fouad
2. N. Ferrara
3. J. Joyce
4. N. Vasudev
5. S. Ostrand-Rosenberg
6. C. Aanei
7. Alicia S. Chung
8. C. Wigerup

Papers from L. Ellis's perspective

Ordered by how strongly the researchers L. Ellis trusts endorse each paper. Same corpus, a different order for every researcher.

1. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. (American Journal of Pathology)
2. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. (Journal of Clinical Oncology)
3. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells (Nature Medicine)
4. Immunobiology of dendritic cells. (Annual Review of Immunology)
5. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
6. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. (Journal of Clinical Oncology)
7. Dendritic cells as therapeutic vaccines against cancer (Nature reviews. Immunology)
8. Molecular mechanisms of lymphangiogenesis in health and disease. (Cancer Cell)
9. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. (Radiology)
10. Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis (Annals of Surgery)

Their papers

• VEGF-targeted therapy: mechanisms of anti-tumour activity (2008) — 1,684 citations
• Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis (2002) — 1,244 citations
• Antiangiogenic therapy in oncology: current status and future directions. (2016) — 736 citations
• Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. (2005) — 2,955 citations
• Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. (2008) — 604 citations
• Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases (2004) — 1,802 citations
• Simplified staging for hepatocellular carcinoma. (2002) — 696 citations
• Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells* (2002) — 807 citations
• Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis (2000) — 766 citations